Propafenone - Isotope Labelled Standards
References
FAQ's
References
- Lietz, Helmut, Preparation of propafenone, BASF A.-G., Federal Republic of Germany, US4474986A, October 2, 1984
- Harapat, Sandra R.; Kates, Robert E., High-performance liquid chromatographic analysis of propafenone in human plasma samples, Journal of Chromatography, Biomedical Applications Volume: 230, Issue: 2, Pages: 448-53, 1982
Frequently Asked Questions
What is the relevance of Propafenone impurity profiling?
The relevance of Propafenone impurity profiling is to ensure the purity, safety, and efficacy of the drug by identifying, quantifying, and controlling impurities that may be present in the formulation.
How are impurities in Propafenone detected and quantified?
Impurities in Propafenone are detected and quantified using analytical techniques such as high-performance liquid chromatography (HPLC) coupled with various detection methods such as mass spectrometry (MS).
What are the risks associated with certain Propafenone impurities?
Some impurities in Propafenone may pose risks such as decreased efficacy, increased toxicity, or potential for adverse reactions and allergies.
What are the temperature conditions required to store Propafenone impurities?
Propafenone impurities are stored preferably at a regulated room temperature of 2-8°C or as specified on the Certificate of Analysis (CoA).
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.